Aoki et al. (1991) used IL2 in the first human adoptive TILs for the therapy of advanced or recurrent EOC: autologous CD8+ TILs taken form pleural effusion were cultured with IL2, expanded and then infused with or without chemotherapy [27]. Here, IL2 is linked to Pleural effusion.